GASTROINTESTINAL STROMAL TUMORS
Clinical trials for GASTROINTESTINAL STROMAL TUMORS explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL STROMAL TUMORS trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL STROMAL TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Terminated trial tests new drug cocktails for tough cancers
Disease control TerminatedThis early-stage study tested two different drug combinations (TNO155 with either spartalizumab or ribociclib) in adults with advanced solid tumors, including lung, head and neck, and colorectal cancers. The main goal was to find safe doses and understand side effects, not to cur…
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Experimental drug tested as last hope for rare, Tough-to-Treat cancers
Disease control TerminatedThis study tested whether a drug called SGI-110 could shrink or slow the growth of certain rare cancers, including specific types of stomach, adrenal, and kidney tumors. It was for patients aged 12 and older whose cancers had not responded to standard treatments. Participants rec…
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC